brain structural (P=.14), neurophysiological (P=.54), and neurochemical (P=.22) alterations. The summary effect size for cardiometabolic alterations (g=0.23; CI:0.15-0.31) was significantly lower than neurochemical (P=.04), neurophysiological (P<.001) and brain structural alterations (P=.001). The overall summary effect sizes for non-CNS (g=0.58; CI:0.44-0.72) and CNS (g=0.50; CI:0.44-0.56) alterations were not significantly different (P=.28). Discussion: These data indicate that there are robust alterations in non-CNS systems in psychosis, and that these are broadly similar in magnitude to a range of CNS alterations, indicating that psychosis involves multiple organ systems to a comparable degree from onset. We consider three models that could account for these findings and discuss implications for future research and treatment. Background: Short telomere length is a biomarker of cell oxidation and aging. Patients with first-episode psychosis (FEP) have been reported to have shorter telomeres than healthy controls (HC), suggesting that there is a premature and accelerated cellular aging in FEP. However, there are not data on longitudinal changes of telomere length in people with FEP relative to HC. We present preliminary results on 1-year longitudinal changes in peripheral blood mononuclear cells (PBMCs) telomere length and the proportion of PBMCs with short telomeres in young people with FEP and HC. Methods: 16 young patients with FEP (43.8% female, mean age 17.9 years) and 21 young HC (61.9% female, mean age 16.6 years) were enrolled in the study. PBMCs telomere length and the proportion of PBMCs with short telomeres (i.e. <3kb) were determined using high-throughput quantitative fluorescence in situ hybridization (HT Q-FISH) at baseline (16 patients with FEP and 21 HC) and 12-month follow-up (4 patients with FEP and 4 HC). Results: At baseline, we did not find significant differences in telomere length nor in proportion of PBMCs with short telomeres between FEP patients and HC. During the one-year follow-up, we found a significantly greater loss of telomere length (p=0.019; explained variance=69.7%) and a non-significantly trend for greater increase in the proportion of PBMCs with short telomeres (p=0.097; explained variance=45.5%) in patients with FEP than in HC. Discussion: Telomere length changes during the first years of the illness can represent an early marker of accelerated cellular aging in patients with firstepisode psychosis.
Background: Short telomere length is a biomarker of cell oxidation and aging. Patients with first-episode psychosis (FEP) have been reported to have shorter telomeres than healthy controls (HC), suggesting that there is a premature and accelerated cellular aging in FEP. However, there are not data on longitudinal changes of telomere length in people with FEP relative to HC. We present preliminary results on 1-year longitudinal changes in peripheral blood mononuclear cells (PBMCs) telomere length and the proportion of PBMCs with short telomeres in young people with FEP and HC. Methods: 16 young patients with FEP (43.8% female, mean age 17.9 years) and 21 young HC (61.9% female, mean age 16.6 years) were enrolled in the study. PBMCs telomere length and the proportion of PBMCs with short telomeres (i.e. <3kb) were determined using high-throughput quantitative fluorescence in situ hybridization (HT Q-FISH) at baseline (16 patients with FEP and 21 HC) and 12-month follow-up (4 patients with FEP and 4 HC). Results: At baseline, we did not find significant differences in telomere length nor in proportion of PBMCs with short telomeres between FEP patients and HC. During the one-year follow-up, we found a significantly greater loss of telomere length (p=0.019; explained variance=69.7%) and a non-significantly trend for greater increase in the proportion of PBMCs with short telomeres (p=0.097; explained variance=45.5%) in patients with FEP than in HC. Discussion: Telomere length changes during the first years of the illness can represent an early marker of accelerated cellular aging in patients with firstepisode psychosis. Background: Functional connectivity differences in the cortico-thalamicstriatal-cortical (CTSC) circuit, as well as altered subcortical region volumes have been observed in schizophrenia. In this study, structural and functional magnetic resonance imaging (MRI) were used in a large child and youth sample aged 11-21 years (n=1134) including children with psychosis spectrum (PS) symptoms (n=312) to further understanding of these biomarkers in youth outside of high risk groups and with a wider range of symptom severity. Methods: Structural subregions of the thalamus and striatum were identified using the segmentation tool MAGeT Brain. Functional subregions were segmented based on functional connectivity with the 7 functional networks identified in Yeo et al, 2011. Average time series from functional subregions were correlated vertex-wide with cortical surfaces and Fisher Z transformed. FSL's PALM was used to examine differences and interactions between PS groups and sex. Age and in scanner motion (mean framewise displacement) were covaried for and a family wise error rate correction was applied. Structural subregion volume differences and interactions between PS groups and sex were investigated statistically using analyses of covariance (ANCOVA) with a false discovery rate of 5% correction for multiple testing. Age, intracranial volume, WRAT score and current medication use were covaried for. Results: Sex-specific differences between PS and non-PS youth in structural subregion volumes were seen in both the striatum and thalamus. There was a persistent pattern of increased volumes in girls with PS symptoms, but decreased volumes in boys with PS symptoms compared to non-PS youth in the bilateral posterior putamen of the striatum (F=9.26, pFDR=0.006), higher order thalamic bilateral pulvinar (F=9.85, pFDR=0.004), left medial dorsal nuclei (F=7.42, pFDR=0.01), as well as first order thalamic left ventral posterior nucleus (F=6.47, pFDR=0.02), medial geniculate nucleus (F=10.03, pFDR=0.004) and bilateral lateral geniculate nuclei (F=5.7, pFDR=0.03). However, both PS girls and boys had increased nucleus accumbens volumes (t=2.66, pFDR=0.02). Decreased functional connectivity was found in PS youth between a striatal subregion in the right posterior putamen (corresponding to the dorsal attention network) and occipital areas (pFWE=0.005). This pattern was found to be driven by differences in specifically PS boys and not PS girls (pFWE=0.004). Discussion: Multiple sex-specific structural differences between PS and non-PS youth were found in striatal and thalamic subregions. Hypoconnectivity between the striatal posterior putamen and occipital regions in PS boys overlap with structural increases in this subcortical volume in PS boys. Finding these early indicators is a key strategy to provide insight into neural mechanisms underlying the development of psychosis with the aim to improve and better target treatments. Background: Neuropsychological deficiencies in attentional processes and filtering of information are shown by both patients with schizophrenia and Attention Deficit Hyperactivity Disorder (ADHD). Given that behavioral symptoms differ, differential neurophysiological processes are likely to be underlying each disorder. Deficiencies in early auditory processing measured by event-related potentials (ERPs) such as the P300 amplitude and mismatch negativity are suggested to be biomarkers for schizophrenia. Here we study if these electrophysiological processes are impaired in, and specific for, young individuals with a first episode psychosis (FEP), by directly comparing them with typically developing peers and adolescents with ADHD. Methods: 27 FEP patients, 25 ADHD patients and 45 age and gender matched Healthy Controls (HC), all aged between 12 and 17 years old, were assessed for their N1, N2, P2, P3a, P3b, MMN and PN amplitudes in a selective attention paradigm (auditory oddball task). Results: ADHD patients showed significantly smaller N2 and P3b amplitudes than HC, whereas FEP patients showed intermediate amplitudes. In addition, we found a second order interaction effect, indicating that the HC group had larger P2 amplitudes to attended deviant stimuli than to unattended deviant stimuli, whereas the response to non-attended deviant stimuli did not differ from that to non-attended standard stimuli. The ADHD group did not show this difference, in fact, they showed P2 amplitudes to unattended deviant stimuli that were larger than those to unattended standards. Interestingly, this effect was also found in the FEP group, although this only reached trend level (p = 0.08) of statistical significance. Post-hoc dividing the FEP group in patients with and without a diagnosis of schizophrenia, showed the same second order interaction effect in patients without schizophrenia as that in the ADHD subjects, while the interaction effect in patients with schizophrenia was identical to that of the HC. Furthermore, FEP patients without schizophrenia showed significantly smaller P3b amplitudes compared to FEP patients with schizophrenia and HC. Last, FEP patients with schizophrenia showed trend level significant smaller MMN amplitudes than HC (p = 0.09). No further significant group differences were found. Discussion: FEP patients without schizophrenia showed impaired neurophysiological functioning compared to their counterparts with schizophrenia, who in turn showed similar performance as healthy controls. Given that use of medication did not differ between FEP patients with and without schizophrenia, our data suggest that other factors may play a role, such as comorbid symptoms. Since we found considerable overlap between FEP patients without schizophrenia and ADHD patients our current data do not support the theory that any of the investigated electrophysiological measures are useful as specific biomarkers for schizophrenia. 
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Background: Although the role of lipid disturbances and inflammation in psychotic disorders have been demonstrated in a substantial body of research, the association between clinical symptomatology and these two important pathways has not been studied in detail. The main aim of this study was to investigate the associations between serum lipid levels [total cholesterol (TC), low density lipoprotein (LDL), triglyceride (TG)]; general or specific inflammatory markers [C-reactive protein (CRP), soluble tumor necrosis factor receptor 1(sTNF-R1), osteoprotegerin (OPG), interleukin 1 receptor antagonist (IL-1Ra)]; and clinical symptoms (positive, negative and depressive) in patients with psychotic disorders. Methods: The sample is consisted of 652 participants divided in two groups: Schizophrenia, schizophreniform and schizoaffective, (schizophrenia group, N = 344); psychosis NOS, psychotic bipolar I, II and NOS, (non-schizophrenia group, N = 308) recruited consecutively between 2003 and 2015 from five major hospitals in Oslo, Norway, as part of Thematically Organized Psychosis (TOP) Study. The Regional Committee for Medical Research Ethics approved the study. Demographic, clinical and medications data were obtained by clinical interviews and from medical records. SCID-I was used for diagnosis in addition to Positive and Negative Syndrome Scale (PANSS) and Calgary Depression Scale for Schizophrenia (CDSS) to assess symptoms severity. Bivariate and multivariate analyses were performed to evaluate associations between symptom profiles, lipid levels and inflammatory markers. Results: Schizophrenia group showed higher levels of TC and LDL compared to non-schizophrenia group after adjusting for age, gender, BMI, smoking, and medications. TC and LDL were positively correlated with depression, whereas TG and LDL were positively correlated with negative symptoms. CRP and OPG were significantly associated with higher levels of TC and LDL. While, sTNF-R1 showed significant positive correlation only with TG. In multivariate regression, higher LDL was significantly associated with higher age, BMI, depressive severity in addition to two inflammatory markers CRP and OPG. Discussion: The findings of this study highlight the importance of understanding the interaction between inflammatory markers and lipid, and their relation to clinical profile especially depression in psychotic disorders
